Prostate Cancer

Prostate cancer is the second most common malignancy, affecting ~1.3 million men every year worldwide. Tragically, there is a treatment paradox, as ~45% of prostate cancer patients experience slow-growing cancer and are unlikely to progress rapidly, while prostate cancer is not curable at advanced stage.
Evidently, clinical management of prostate cancer is not optimal, as patients which do not require treatment are over-treated, while for those that immediate actions are required, efficient treatment are still needed.